只有PH域的蛋白质PHLDA3是Akt的p53调节抑制剂
Tatsuya Kawase1, Rieko Ohki, Tatsuhiro Shibata
1Radiobiology Division, National Cancer Center Research Institute, Tokyo, Japan.
Cell
|February 11, 2009
概括
瘤抑制剂p53激活PHLDA3,从而抑制了Akt的信号传输. 失去PHLDA3促进癌症生长,揭示了p53和Akt之间的瘤抑制的新联系.
科学领域:
- 分子生物学分子生物学
- 癌症生物学 癌症生物学
- 细胞信号传递 细胞信号传递
背景情况:
- 在瘤发生过程中,p53和Akt信号通路在调节细胞存活和死亡方面发挥着至关重要的,相反的作用.
- 通过对目标基因进行交换激活,p53作为瘤抑制剂,而Akt通过下游信号促进细胞存活.
- 这些通路参与一个负反循环,以维持细胞平衡.
研究的目的:
- 识别和描述参与调节Akt路径的新型p53点基因.
- 阐明 PHLDA3 影响 Akt 激活和细胞过程的机制.
- 研究PHLDA3在瘤抑制中的作用,特别是在肺癌中.
主要方法:
- 确定PHLDA3作为p53的目标基因.
- 生物化学测试以评估PHLDA3与Akt和膜脂质的相互作用.
- 涉及PHLDA3剥离的细胞实验,以评估Akt活动,细胞亡和独立于 anchorage的生长.
- 在原发性肺癌样本中分析PHLDA3基因组位置.
主要成果:
- PHLDA3,一种仅含PH域的蛋白质,被确定为直接的p53点基因.
- 通过竞争膜脂质结合,PHLDA3抑制了Akt的激活,从而阻止了Akt的转移.
- 除PHLDA3会导致Akt活性增加,减少p53依赖的细胞亡,并增强 anchorage-independent细胞生长.
- 在肺癌中观察到PHLDA3基因组位置的频繁丧失.
结论:
- 通过抑制支持生存的Akt路径,PHLDA3起到瘤抑制作用.
- 这项研究揭示了由PHLDA3.3调解的p53和Akt通路之间的交叉交谈的新机制.
- PHLDA3功能障碍有助于瘤发生,突出其作为治疗点的潜力.
相关概念视频
Phosphorylation
44.8K
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
44.8K
Negative Regulator Molecules
32.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
Protein Kinases and Phosphatases
12.2K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
12.2K
Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
The JAK-STAT Signaling Pathway
10.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
10.3K
PI3K/mTOR/AKT Signaling Pathway
5.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.2K


